Target intelligence / Profile preview

Adenosine monophosphate-activated protein kinase (AMPK) (AMPK)

Target
AMPK
Molecular classification
Enzyme, Serine/threonine protein kinase, Heterotrimeric protein complex
01

Overview

Adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved heterotrimeric enzyme complex that serves as the master regulator of cellular energy homeostasis [UniProt P54646]. It consists of a catalytic alpha subunit and regulatory beta and gamma subunits, which allow it to sense fluctuations in the cellular AMP:ATP and ADP:ATP ratios [Hardie et al., 2012, Nature Reviews Molecular Cell Biology]. When energy levels are low, AMPK is activated to restore balance by promoting catabolic pathways that generate ATP, such as glucose uptake and fatty acid oxidation, while simultaneously inhibiting energy-consuming anabolic processes like lipid and protein synthesis [PubMed: 22551880]. Due to its central role in metabolism, AMPK is a primary therapeutic target for type 2 diabetes and metabolic syndrome, with metformin being its most well-known indirect activator [PubChem: 4091]. Furthermore, AMPK's influence on cell growth, autophagy, and mitochondrial health has made it a subject of intense research in oncology and neurodegenerative diseases [PubMed: 27229108].

Other names
5'-AMP-activated protein kinasePRKAAMP-activated protein kinaseHMG-CoA reductase kinase
02

Mechanism of action

AMPK acts as a cellular energy sensor activated by increases in the AMP:ATP and ADP:ATP ratios. It is activated allosterically by AMP/ADP binding to the gamma subunit and by phosphorylation of the alpha subunit at Thr172 by upstream kinases such as LKB1 and CaMKK2 [Hardie et al., 2012, Nature Reviews Molecular Cell Biology]. Once active, AMPK phosphorylates downstream targets to switch off ATP-consuming anabolic pathways and switch on ATP-producing catabolic pathways.

03

Biological functions

Energy homeostasisMetabolic regulationGlucose uptakeFatty acid oxidationAutophagyMitochondrial biogenesisLipid metabolism
04

Disease associations

Type 2 diabetesObesityMetabolic syndromeCancerCardiovascular diseaseNon-alcoholic fatty acid liver disease (NAFLD)
05

Safety considerations

Potential for cardiac hypertrophy (associated with PRKAG2 mutations)Risk of lactic acidosis (primarily with biguanides)Context-dependent role in cancer (may promote survival of established tumors)Potential skeletal muscle effects
06

Interacting drugs

Metformin

7 more in the full profile.

07

Biomarkers

Phospho-AMPK (Thr172)Phospho-ACC (Ser79)Blood glucose levelsHbA1c

Beyond the preview

Go deeper on Adenosine monophosphate-activated protein kinase (AMPK) (AMPK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenosine monophosphate-activated protein kinase (AMPK) (AMPK).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call